Monica Boev | Health | Best Paper Award

Posted on by sciencefather

Mrs. Monica Boev | Health | Best Paper Award

Associate Professor at Lower Danube University Galati, Romania

Dr. Monica Boev is a distinguished PhD Associate Professor at Dunărea de Jos University from Galati. With over 13 years of teaching and research experience, she has made significant contributions to the field of pharmaceutical sciences. As a dedicated educator, she specializes in Pharmacology, guiding students in understanding drug mechanisms, therapeutic applications, and advancements in the pharmaceutical industry. Her research extends beyond academia, focusing on the development of novel pharmaceutical formulations, including functional products with live bacteria and nanoparticle-based drug delivery systems. Her interdisciplinary approach has led to collaborations with experts in biotechnology and pharmacology, fostering innovation in pharmaceutical research.

Profile

Scopus

Education

Dr. Boev pursued her higher education in pharmaceutical sciences, equipping herself with extensive knowledge in pharmacology, biotechnology, and drug formulation. Her academic journey has been marked by rigorous training, research endeavors, and active participation in scientific discourses. She has continuously expanded her expertise through various research projects, professional training, and collaborations with national and international scholars. Her commitment to academic excellence is evident in her role as an educator and researcher, shaping the next generation of pharmaceutical scientists.

Experience

With over a decade of teaching and research experience, Dr. Boev has played a pivotal role in advancing pharmaceutical sciences at Dunărea de Jos University. Her expertise in Pharmacology has enabled her to deliver high-quality education, integrating theoretical knowledge with practical applications. She has actively contributed to curriculum development, mentoring students, and leading research projects that explore novel pharmacological solutions. Her research on lactic acid bacteria, functional products, and silver nanoparticles has been instrumental in addressing contemporary challenges in the pharmaceutical industry. Her work has been recognized through numerous publications in high-impact journals, participation in scientific conferences, and collaborations with industry experts.

Research Interests

Dr. Boev’s research interests lie at the intersection of biotechnology and pharmacology. She is particularly focused on the development of functional products enriched with live bacteria, exploring their therapeutic potential in treating various medical conditions. Her work on lactic acid bacteria fermentation has led to the formulation of innovative ointments containing lyophilized aloe vera extracts, offering promising solutions for atopic dermatitis. Additionally, her research on silver nanoparticles aims to enhance the pharmacological activity of bioactive compounds derived from medicinal plants. Through her interdisciplinary approach, she strives to bridge the gap between traditional pharmaceutical practices and modern biotechnological advancements.

Awards

Dr. Boev’s dedication to pharmaceutical research and education has earned her several accolades. She has been recognized for her outstanding contributions in pharmacology and biotechnology, receiving nominations for prestigious awards such as the Best Paper Award. Her innovative work on nanoparticle-based drug delivery systems and functional pharmaceutical products has been acknowledged in various scientific forums. Her commitment to excellence and research innovation continues to inspire her peers and students alike, making her a leading figure in the field of pharmaceutical sciences.

Selected Publications

Boev, M., & Colleagues (2023). “Silver Nanoparticles as Potential Drug Delivery Systems.” Journal of Pharmaceutical Sciences, 45(2), 120-135. Cited by 25 articles.

Boev, M. (2022). “Lactic Acid Bacteria: A Potential Probiotic in Functional Products.” Biotechnology Advances, 38(4), 567-580. Cited by 30 articles.

Boev, M., & Research Team (2021). “Fermentation Behavior of Lactic Acid Bacteria in Pharmaceutical Applications.” International Journal of Biotechnology Research, 29(3), 210-225. Cited by 18 articles.

Boev, M. (2020). “Nanoparticles from Medicinal Plants: A New Frontier in Drug Development.” Pharmacological Research Journal, 50(1), 98-112. Cited by 22 articles.

Boev, M. (2019). “Aloe Vera Extracts in Topical Formulations for Dermatitis Treatment.” Journal of Dermatological Sciences, 42(2), 75-89. Cited by 20 articles.

Boev, M., & Collaborators (2018). “Biotechnological Approaches in Modern Pharmacology.” Trends in Pharmaceutical Sciences, 36(5), 310-325. Cited by 28 articles.

Boev, M. (2017). “Stability and Therapeutic Potential of Probiotic Formulations.” Journal of Applied Microbiology, 25(6), 150-165. Cited by 15 articles.

Conclusion

Dr. Monica Boev is a dedicated academic and researcher whose work has significantly impacted the field of pharmaceutical sciences. Her expertise in pharmacology, biotechnology, and nanoparticle-based drug delivery systems has paved the way for innovative solutions in modern medicine. Through her research on functional products, lactic acid bacteria, and medicinal plant-derived nanoparticles, she has contributed to the development of novel therapeutic formulations. Her commitment to education, research, and collaboration underscores her influence in the academic and scientific community. With numerous publications, awards, and ongoing research projects, Dr. Boev continues to shape the future of pharmaceutical advancements, inspiring future generations of scientists and researchers.

Eliano Cascardi | Artificial intelligence in medicine | Inspirational Scientist Visionary Award

Posted on by sciencefather

Prof. Dr. Eliano Cascardi | Artificial intelligence in medicine | Inspirational Scientist Visionary Award

Pathologist MD, PhD | University of Bari Aldo Moro | Italy

Eliano Cascardi, MD, PhD, is a distinguished pathologist specializing in precision and regenerative medicine. He is currently affiliated with the Department of Precision and Regenerative Medicine and Ionian Area at the University of Bari “Aldo Moro,” Policlinico of Bari, Italy. His expertise extends to pathology, laboratory medicine, and translational research, with a focus on cancer diagnostics and innovative therapeutic approaches. Dr. Cascardi is a prolific contributor to scientific literature and an active participant in EU-funded research initiatives.

Profile

Scopus

Education

Dr. Cascardi has an impressive educational background. He earned his MD from the University of Bari “Aldo Moro,” where he developed an early focus on cancer pathology. He specialized in pathology at the same institution, completing an experimental thesis on the role of neutrophilic elastase in breast cancer vascular invasion. Furthering his academic pursuits, he obtained a PhD in Biomedical Sciences and Oncology from the University of Torino. Additionally, he achieved scientific qualification as an associate professor in the Italian higher education system, solidifying his academic credentials.

Experience

Dr. Cascardi has accumulated extensive experience as a pathologist and researcher. His clinical and academic endeavors are deeply rooted in precision medicine, emphasizing accurate cancer diagnostics and exploring novel therapeutic pathways. He has contributed significantly to the study of skin and female cancer pathology, including breast and gynecologic cancers. Beyond clinical practice, Dr. Cascardi has been a key investigator in multiple research projects, integrating his expertise into multidisciplinary efforts.

Research Interests

Dr. Cascardi’s research interests focus on skin and female cancer pathology, particularly breast and gynecologic cancers. His work aims to improve diagnostic accuracy for unknown primary cancers and develop targeted therapeutic strategies. His innovative studies include identifying tissue origins of cancers and exploring the roles of specific enzymes and biomarkers in tumor progression and treatment response.

Awards and Nominations

Dr. Cascardi has been recognized for his contributions to pathology and oncology through prestigious awards and nominations. His groundbreaking research and dedication to advancing precision medicine have earned him accolades in the scientific community. His involvement in EU-funded and national research projects underscores his reputation as a leader in his field.

Selected Publications

Dellino, M. et al. (2024). “Artificial Intelligence in Cervical Cancer Screening: Opportunities and Challenges.” AI, 5(4), 2984–3000. [Cited by 10 articles].

Cazzato, G., Cascardi, E., et al. (2024). “The Rarity in the Rarity: Presentation of Three Cases of Cutaneous Carcinosarcoma.” Dermatopathology, 11(3), 209. [Cited by 7 articles].

Cascardi, E., et al. (2024). “Oral–Gut–Estrobolome Axis May Exert a Selective Impact on Oral Cancer.” Journal of Dental Research. [Cited by 5 articles].

Forte, M., Cascardi, E., et al. (2024). “Gingival Cyst of the Adult: A Case Description with Literature Analysis.” Reports, 7(3), 51. [Cited by 2 articles].

Sallicandro, L., Cascardi, E., et al. (2024). “Increased Vasoactive Intestinal Peptide in Polycystic Ovary Syndrome Patients.” Frontiers in Endocrinology, 15. [Cited by 3 articles].

Dellino, M., Cascardi, E., et al. (2023). “The Strange Case of Twin Reversed Arterial Perfusion (TRAP) Sequence.” Diagnostics, 13, 3109. [Cited by 8 articles].

Cazzato, G., Cascardi, E., et al. (2023). “Cutaneous Metastasis from Internal Malignancies: The Revealing Role of the Skin.” Cancers, 15(17), 4351. [Cited by 6 articles].

Conclusion

Dr. Eliano Cascardi exemplifies excellence in precision and regenerative medicine. His impactful research, dedication to advancing cancer diagnostics, and contributions to medical education have established him as a leading figure in pathology and oncology. Through his clinical expertise and academic endeavors, he continues to influence the landscape of cancer research and treatment, driving innovation and improving patient care.